source · text/csv
source_e9d1f957f712489a
sha256 1c2899cf789f71f74e5ec8941003cda8aeccbc04c52b058e60316a881d180acf
by researka:v2 · 2026-06-20 00:34:54.289862+04:00
study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness The effect of acarbose on lipid profiles in adults: a systematic review and meta-analysis of randomized clinical trials,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level The effects of acarbose therapy on reductions of myocardial infarction and all-cause death in T2DM during 10-year multifactorial interventions (The Beijing Community Diabetes Study 24),not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary "Efficacy and safety of alogliptin versus acarbose in Chinese type 2 diabetes patients with high cardiovascular risk or coronary heart disease treated with aspirin and inadequately controlled with metformin monotherapy or drug‐naive: A multicentre, randomized, open‐label, prospective study ( ACADEMIC",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level Acarbose Reduces Low-Grade Albuminuria Compared to Metformin in Chinese Patients with Newly Diagnosed Type 2 Diabetes,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary "The Supportive Effect of Acarbose to Orlistat in Weight Management—A Randomized, Double‐Blind, Multiarm Phase 2 Trial",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary "Effect of acarbose and vildagliptin on plasma trimethylamine N-oxide levels in patients with type 2 diabetes mellitus: a 6-month, two-arm randomized controlled trial",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Acarbose With Comparable Glucose-Lowering but Superior Weight-Loss Efficacy to Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level Evaluation of the Bioequivalence of Acarbose in Healthy Chinese People,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Acarbose or Canagliflozin vs. Placebo to Ameliorate Post‐Bariatric Hypoglycaemia: The Clinical Outcomes of the HypoBar I Randomised Clinical Trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Method for evaluating the human bioequivalence of acarbose based on pharmacodynamic parameters,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Acarbose for Postprandial Hypotension With Glucose Metabolism Disorders: A Systematic Review and Meta-Analysis,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level The Effects of Acarbose on the Postprandial Hypotensive Response in Older Adults.,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level "The gerotherapeutic drugs rapamycin, acarbose, and phenylbutyrate extend lifespan and enhance healthy aging in house crickets",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level The Effects of Acarbose on Non-Diabetic Overweight and Obese Patients: A Meta-Analysis.,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level "**Outcome class** is assigned from the source's bound endpoint, population, and claim text; adjacent/background sources are separated from clinical outcome slices.",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation "**Directness** is coded as direct only when a source tests the topic against a clinically proximate outcome in the relevant population; a qualifying direct source would be a human interventional or hard-endpoint study of the topic itself. Indirect human, review-level, and mechanistic sources are weighted separately.",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation "**Directional signal** is counted within the assigned outcome class only. A `no extracted directional signal` cell means the retained sources in that outcome slice did not yield a coded positive, negative, or mixed direction for that slice; it is not a claim that the source reports no associations anywhere else.",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation **Evidence tier** follows the deterministic tier/directness taxonomy used in the source builder; the prose writer cannot move a source between classes after sources are frozen.,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation Studenski 2011,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation Cesari 2009,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation Perera 2006,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation ADA 2024,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation WHO 2000,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation Bohannon 1997,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation Cruz-Jentoft 2019,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation Anisimov 2008,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation Tancredi 2015,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation Ioannidis 2005,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,citation
metadata
{
"researka_object_type": "publication_sidecar",
"researka_publication_id": "08943c0f-97ab-41e2-820b-bf2dbe384513",
"researka_submission_id": "c692a542-ec48-4973-8fc0-452c722f7c5d",
"sidecar_name": "evidence_table.csv",
"sidecar_url": "https://api.researka.org/publications/08943c0f-97ab-41e2-820b-bf2dbe384513/sidecars/evidence_table.csv"
}